These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 17869376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
    Christen Y.
    J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V, Pan TH, LE WD.
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L, Rockenstein E, Masliah E.
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [Abstract] [Full Text] [Related]

  • 6. Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases.
    Ebert S, Goos M, Rollwagen L, Baake D, Zech WD, Esselmann H, Wiltfang J, Mollenhauer B, Schliebs R, Gerber J, Nau R.
    J Neurosci Res; 2010 Apr; 88(5):1124-36. PubMed ID: 19859962
    [Abstract] [Full Text] [Related]

  • 7. [Animal models of neurodegenerative diseases].
    Langui D, Lachapelle F, Duyckaerts C.
    Med Sci (Paris); 2007 Feb; 23(2):180-6. PubMed ID: 17291428
    [Abstract] [Full Text] [Related]

  • 8. Transgenic models of alpha-synuclein pathology: past, present, and future.
    Hashimoto M, Rockenstein E, Masliah E.
    Ann N Y Acad Sci; 2003 Jun; 991():171-88. PubMed ID: 12846986
    [Abstract] [Full Text] [Related]

  • 9. [Experimental models in Alzheimer's disease].
    Manzano S, González J, Marcos A, Payno M, Villanueva C, Matías-Guiu J.
    Neurologia; 2009 May; 24(4):255-62. PubMed ID: 19603296
    [Abstract] [Full Text] [Related]

  • 10. Drosophila models of human neurodegenerative disease.
    Chan HY, Bonini NM.
    Cell Death Differ; 2000 Nov; 7(11):1075-80. PubMed ID: 11139281
    [Abstract] [Full Text] [Related]

  • 11. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
    Link CD.
    Exp Gerontol; 2006 Oct; 41(10):1007-13. PubMed ID: 16930903
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F, Wei X, Nölker C, Bacher M, Du Y, Dodel R.
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of Alzheimer disease].
    Kovács T.
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [Abstract] [Full Text] [Related]

  • 14. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia.
    Jellinger KA.
    Neurodegener Dis; 2008 Mar; 5(3-4):118-21. PubMed ID: 18322367
    [Abstract] [Full Text] [Related]

  • 15. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
    Letiembre M, Liu Y, Walter S, Hao W, Pfander T, Wrede A, Schulz-Schaeffer W, Fassbender K.
    Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
    [Abstract] [Full Text] [Related]

  • 16. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S, Pérez-Neri I, Ríos C, Tristán-López L, Rivera-Espinosa L, Montes S.
    Chem Biol Interact; 2010 Jul 30; 186(2):184-99. PubMed ID: 20399203
    [Abstract] [Full Text] [Related]

  • 17. Visual aspects of neurologic protein misfolding disorders.
    Pula JH, Kim J, Nichols J.
    Curr Opin Ophthalmol; 2009 Nov 30; 20(6):482-9. PubMed ID: 19816176
    [Abstract] [Full Text] [Related]

  • 18. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
    Hachiya NS, Kozuka Y, Kaneko K.
    Med Hypotheses; 2008 Nov 30; 70(5):1034-7. PubMed ID: 17910993
    [Abstract] [Full Text] [Related]

  • 19. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G, Schlüter OM, Südhof TC.
    Nat Neurosci; 2008 Mar 30; 11(3):301-8. PubMed ID: 18297066
    [Abstract] [Full Text] [Related]

  • 20. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K, Higuchi K, Ikeda S.
    Brain Nerve; 2012 Jun 30; 64(6):665-74. PubMed ID: 22647474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.